Literature DB >> 7608709

Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study.

M M Reilly1, H Staunton, A E Harding.   

Abstract

A cluster of cases of familial amyloid polyneuropathy has been described in Donegal, north west Ireland. Two patients from this region have been shown to have the ala 60 mutation in the transthyretin gene. Three kindreds with this mutation have also been described in the United States. Genealogical and haplotype studies indicate that all known patients with this mutation are related and are descended from a founder in north west Ireland. There is evidence for reduced penetrance of this disorder. A population based study showed that 1.1% of the population in this area in north west Ireland carry the mutation. This has implications in terms of diagnosis, genetic counselling, and treatment in the future.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608709      PMCID: PMC1073600          DOI: 10.1136/jnnp.59.1.45

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Irish (Donegal) amyloidosis is associated with the transthyretinALA60 (Appalachian) variant.

Authors:  H Staunton; M B Davis; R J Guiloff; M Nakazato; N Miyazato; A E Harding
Journal:  Brain       Date:  1991-12       Impact factor: 13.501

2.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

3.  Hereditary amyloid polyneuropathy in north west Ireland.

Authors:  H Staunton; P Dervan; R Kale; R P Linke; P Kelly
Journal:  Brain       Date:  1987-10       Impact factor: 13.501

4.  Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30).

Authors:  G Holmgren; L Steen; J Ekstedt; C G Groth; B G Ericzon; S Eriksson; O Andersen; I Karlberg; G Nordén; M Nakazato
Journal:  Clin Genet       Date:  1991-09       Impact factor: 4.438

Review 5.  Familial amyloid polyneuropathy.

Authors:  M M Reilly; R H King
Journal:  Brain Pathol       Date:  1993-04       Impact factor: 6.508

6.  Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Appalachian amyloid.

Authors:  M D Benson; M R Wallace; E Tejada; H Baumann; B Page
Journal:  Arthritis Rheum       Date:  1987-02

7.  Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations.

Authors:  S Ii; S Minnerath; K Ii; P J Dyck; S S Sommer
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

8.  Familial amyloid polyneuropathy: alanine-for-threonine substitution in the transthyretin (prealbumin) molecule.

Authors:  A H Koeppen; M R Wallace; M D Benson; K Altland
Journal:  Muscle Nerve       Date:  1990-11       Impact factor: 3.217

9.  The high frequency of TTR M30 in familial amyloidotic polyneuropathy is not due to a founder effect.

Authors:  S Ii; S S Sommer
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

10.  A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family.

Authors:  M D Benson; J C Turpin; G Lucotte; S Zeldenrust; B LeChevalier; M D Benson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

View more
  16 in total

Review 1.  Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Frederick L Ruberg; Martha Grogan; Mazen Hanna; Jeffery W Kelly; Mathew S Maurer
Journal:  J Am Coll Cardiol       Date:  2019-06-11       Impact factor: 24.094

Review 2.  Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Sabahat Bokhari; Thibaud Damy; Sharmila Dorbala; Brian M Drachman; Marianna Fontana; Martha Grogan; Arnt V Kristen; Isabelle Lousada; Jose Nativi-Nicolau; Candida Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Ronald Witteles; Giampaolo Merlini
Journal:  Circ Heart Fail       Date:  2019-09-04       Impact factor: 8.790

Review 3.  The genetics of cardiac amyloidosis.

Authors:  Scott Arno; Jennifer Cowger
Journal:  Heart Fail Rev       Date:  2021-09-13       Impact factor: 4.654

Review 4.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

Review 5.  Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.

Authors:  Joel N Buxbaum; Frederick L Ruberg
Journal:  Genet Med       Date:  2017-01-19       Impact factor: 8.822

Review 6.  Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapies.

Authors:  Rabah Alreshq; Frederick L Ruberg
Journal:  Curr Opin Cardiol       Date:  2021-05-01       Impact factor: 2.161

Review 7.  Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.

Authors:  Antonia Carroll; P James Dyck; Mamede de Carvalho; Marina Kennerson; Mary M Reilly; Matthew C Kiernan; Steve Vucic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-03-07       Impact factor: 13.654

8.  Approach to a patient with cardiac amyloidosis.

Authors:  Christopher Strouse; Alexandros Briasoulis; Rafael Fonseca; Yogesh Jethava
Journal:  J Geriatr Cardiol       Date:  2019-07       Impact factor: 3.327

Review 9.  Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.

Authors:  Hiroyuki Yamamoto; Tomoki Yokochi
Journal:  ESC Heart Fail       Date:  2019-09-25

Review 10.  Diagnosis of Transthyretin Amyloid Cardiomyopathy.

Authors:  Adam S Hafeez; Anthony A Bavry
Journal:  Cardiol Ther       Date:  2020-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.